RIGL
RIGEL PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$46.72
+1.63%Forward multiples
Based on analyst estimates
- P/E forward
- 13.37x
- P/E 2026E
- 13.75x
- P/E 2027E
- 10.29x
- P/E 2028E
- 8.04x
- P/S forward
- 2.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.64x
- PEG TTM
- —
- Price / book
- 2.05x
- Price / sales
- 3.15x
- Price / cash flow
- 10.99x
Enterprise value
- Enterprise value
- $817.3M
- EV / sales
- 2.95x
- EV / EBITDA
- 8.69x
- EV / EBIT
- 9.39x
- Market cap
- $872.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026